NO150639C - Analogifremgangsmaate for fremstilling av terapeutisk aktive lactam-n-eddiksyrer og deres amider - Google Patents
Analogifremgangsmaate for fremstilling av terapeutisk aktive lactam-n-eddiksyrer og deres amiderInfo
- Publication number
- NO150639C NO150639C NO791477A NO791477A NO150639C NO 150639 C NO150639 C NO 150639C NO 791477 A NO791477 A NO 791477A NO 791477 A NO791477 A NO 791477A NO 150639 C NO150639 C NO 150639C
- Authority
- NO
- Norway
- Prior art keywords
- alkyleneimino
- acetic acids
- amids
- preparation
- therapeutic active
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
- C07D223/10—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D227/00—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00
- C07D227/02—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D227/06—Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups C07D203/00 - C07D225/00 with only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D227/08—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polyamides (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1816078 | 1978-05-08 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO791477L NO791477L (no) | 1979-11-09 |
| NO150639B NO150639B (no) | 1984-08-13 |
| NO150639C true NO150639C (no) | 1984-11-21 |
Family
ID=10107678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO791477A NO150639C (no) | 1978-05-08 | 1979-05-03 | Analogifremgangsmaate for fremstilling av terapeutisk aktive lactam-n-eddiksyrer og deres amider |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4221789A (enExample) |
| EP (1) | EP0005689B1 (enExample) |
| JP (1) | JPS54154760A (enExample) |
| AT (1) | ATE27T1 (enExample) |
| AU (1) | AU522815B2 (enExample) |
| BE (1) | BE876067A (enExample) |
| CA (1) | CA1119593A (enExample) |
| DE (2) | DE2960194D1 (enExample) |
| DK (1) | DK150064C (enExample) |
| ES (1) | ES480299A1 (enExample) |
| FI (1) | FI66602C (enExample) |
| FR (1) | FR2425433A1 (enExample) |
| GR (1) | GR67631B (enExample) |
| HU (1) | HU178362B (enExample) |
| IT (1) | IT7948950A0 (enExample) |
| NL (1) | NL7903536A (enExample) |
| NO (1) | NO150639C (enExample) |
| PL (1) | PL117056B1 (enExample) |
| PT (1) | PT69582A (enExample) |
| SE (1) | SE7903864L (enExample) |
| SU (2) | SU1093245A3 (enExample) |
| YU (1) | YU41340B (enExample) |
| ZA (1) | ZA792175B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2944456C2 (de) * | 1979-11-03 | 1982-04-01 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Herstellung von N-α -Alkoxyalkyl-carbonsäureamiden |
| US4396616A (en) * | 1981-09-04 | 1983-08-02 | Merck & Co., Inc. | Substituted enantholactam derivatives as antihypertensives |
| EP0089900B1 (en) * | 1982-03-24 | 1985-12-27 | Prodes S.A. | New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts |
| US4608201A (en) * | 1984-05-21 | 1986-08-26 | Ppg Industries, Inc. | Process for preparing lactam imides |
| CA1322199C (en) * | 1987-07-15 | 1993-09-14 | Masami Eigyo | N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia |
| IT1242043B (it) * | 1990-12-21 | 1994-02-02 | Sigma Tau Ind Farmaceuti | Derivati della 1,2,3,4,-tetraidronaftilammina ad attivita' nootropica e composizioni farmaceutiche che li contengono. |
| IT1245870B (it) * | 1991-06-05 | 1994-10-25 | Sigma Tau Ind Farmaceuti | 3-acilammino-2-pirrolidinoni quali attivatori dei processi di appremdimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
| US5510477A (en) * | 1994-03-01 | 1996-04-23 | The Procter & Gamble Company | Process for the acylation of lactams |
| US5914332A (en) | 1995-12-13 | 1999-06-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| AU1369001A (en) * | 1995-12-13 | 2001-03-22 | Abbott Laboratories | Retroviral protease inhibiting compounds |
| US7834043B2 (en) | 2003-12-11 | 2010-11-16 | Abbott Laboratories | HIV protease inhibiting compounds |
| DK2346500T3 (en) * | 2008-10-16 | 2017-07-17 | Univ Johns Hopkins | Methods and compositions for improving cognitive function |
| EP2533645B1 (en) * | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
| EP2968237A4 (en) | 2013-03-15 | 2016-08-31 | Univ Johns Hopkins | METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION |
| EP2968220B1 (en) | 2013-03-15 | 2021-05-05 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| MX384391B (es) | 2015-05-22 | 2025-03-14 | Agenebio Inc | Composiciones farmacéuticas de levetiracetam de liberación extendida. |
| JP6785838B2 (ja) | 2015-08-05 | 2020-11-18 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 新規な置換グリシン誘導のｆｘｉａ阻害剤 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2657215A (en) * | 1950-03-10 | 1953-10-27 | Goodrich Co B F | Method for the preparation of novel n-(2-carboxyalkyl) succinimides |
| DE1081896B (de) * | 1959-03-28 | 1960-05-19 | Bayer Ag | Verfahren zur Herstellung von ª-Amino-ª-hydroxycarbonsaeuren |
| GB1039113A (en) | 1964-08-06 | 1966-08-17 | Ucb Sa | New n-substituted lactams |
| GB1309692A (en) | 1970-02-13 | 1973-03-14 | Ucb Sa | N-substituted lactams |
| US3751262A (en) * | 1970-06-30 | 1973-08-07 | Allied Chem | Ruminant feed supplement |
| GB1539817A (en) * | 1976-10-22 | 1979-02-07 | Ucb Sa | N-substituted lactams |
-
1979
- 1979-05-02 DE DE7979870012T patent/DE2960194D1/de not_active Expired
- 1979-05-02 AT AT79870012T patent/ATE27T1/de not_active IP Right Cessation
- 1979-05-02 EP EP79870012A patent/EP0005689B1/fr not_active Expired
- 1979-05-03 NO NO791477A patent/NO150639C/no unknown
- 1979-05-03 FI FI791421A patent/FI66602C/fi not_active IP Right Cessation
- 1979-05-03 SE SE7903864A patent/SE7903864L/xx unknown
- 1979-05-03 DK DK182379A patent/DK150064C/da not_active IP Right Cessation
- 1979-05-04 NL NL7903536A patent/NL7903536A/xx not_active Application Discontinuation
- 1979-05-07 ZA ZA792175A patent/ZA792175B/xx unknown
- 1979-05-07 US US06/036,987 patent/US4221789A/en not_active Expired - Lifetime
- 1979-05-07 PL PL1979215420A patent/PL117056B1/pl unknown
- 1979-05-07 AU AU46816/79A patent/AU522815B2/en not_active Expired
- 1979-05-07 PT PT69582A patent/PT69582A/pt unknown
- 1979-05-07 ES ES480299A patent/ES480299A1/es not_active Expired
- 1979-05-07 FR FR7911537A patent/FR2425433A1/fr not_active Withdrawn
- 1979-05-07 CA CA000325925A patent/CA1119593A/en not_active Expired
- 1979-05-07 GR GR59038A patent/GR67631B/el unknown
- 1979-05-07 BE BE1/9378A patent/BE876067A/xx unknown
- 1979-05-07 IT IT7948950A patent/IT7948950A0/it unknown
- 1979-05-08 HU HU79UE94A patent/HU178362B/hu not_active IP Right Cessation
- 1979-05-08 DE DE19792918523 patent/DE2918523A1/de not_active Withdrawn
- 1979-05-08 YU YU1069/79A patent/YU41340B/xx unknown
- 1979-05-08 JP JP5622979A patent/JPS54154760A/ja active Granted
- 1979-05-08 SU SU792763201A patent/SU1093245A3/ru active
- 1979-11-26 SU SU792847114A patent/SU969701A1/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| AU522815B2 (en) | 1982-06-24 |
| DE2960194D1 (en) | 1981-04-16 |
| ES480299A1 (es) | 1980-08-16 |
| DK182379A (da) | 1979-11-09 |
| ZA792175B (en) | 1980-05-28 |
| SU1093245A3 (ru) | 1984-05-15 |
| NL7903536A (nl) | 1979-11-12 |
| SU969701A1 (ru) | 1982-10-30 |
| FI66602C (fi) | 1984-11-12 |
| FI66602B (fi) | 1984-07-31 |
| FI791421A7 (fi) | 1979-11-09 |
| EP0005689A1 (fr) | 1979-11-28 |
| PL215420A1 (enExample) | 1980-02-11 |
| NO791477L (no) | 1979-11-09 |
| AU4681679A (en) | 1979-11-15 |
| BE876067A (fr) | 1979-11-07 |
| NO150639B (no) | 1984-08-13 |
| US4221789A (en) | 1980-09-09 |
| YU41340B (en) | 1987-02-28 |
| PT69582A (fr) | 1979-06-01 |
| DK150064C (da) | 1987-06-15 |
| CA1119593A (en) | 1982-03-09 |
| JPS54154760A (en) | 1979-12-06 |
| YU106979A (en) | 1983-04-30 |
| JPS6220982B2 (enExample) | 1987-05-11 |
| IT7948950A0 (it) | 1979-05-07 |
| GR67631B (enExample) | 1981-09-01 |
| DE2918523A1 (de) | 1979-11-15 |
| EP0005689B1 (fr) | 1981-03-18 |
| SE7903864L (sv) | 1979-11-09 |
| DK150064B (da) | 1986-12-01 |
| PL117056B1 (en) | 1981-07-31 |
| HU178362B (en) | 1982-04-28 |
| FR2425433A1 (fr) | 1979-12-07 |
| ATE27T1 (de) | 1981-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO150639C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive lactam-n-eddiksyrer og deres amider | |
| NO154582C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider. | |
| NO172580C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte n-(1-alkyl-3-hydroksy-4-piperidinyl)benzamider | |
| NO142400C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive, nye benzimidazolinon-derivater | |
| ATE2265T1 (de) | Sekundaere amine, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen. | |
| SE7514271L (sv) | Sett att framstella nya 1,3-disubstituerade propanol-(2)-derivat | |
| NO155244C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-substituert-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer fra deres tilsvarende nitriler. | |
| NO172490C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater | |
| SE7701187L (sv) | Nya piperazinderivat och sett att framstella desamma | |
| NO156566C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridiner. | |
| NO175637C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 6-fluor-3,5-dihydroksykarboksylsyrer og derivater derav | |
| SE7909514L (sv) | Nya halofenyl-pyridyl-allylaminderivat | |
| NO167978C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler. | |
| IT7967658A0 (it) | 2 4 etil i pipera inil 4 fenilchinoline procedimento per la loro prepara ione e composizioni farmaceutiche contenenti tali composti | |
| ES435361A1 (es) | Un metodo para la preparacion de nuevos esteres alcohilicosde aminoacidos. | |
| SE8903312L (sv) | New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them | |
| NO865180L (no) | Fremgangsmaate for fremstilling av 5-aminoalkyl-beta-carbolin-derivater. | |
| DK364386A (da) | 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse | |
| ES440208A1 (es) | Procedimiento para la fabricacion de derivados de piperazi- na. | |
| SE8903313D0 (sv) | New 2-methoxycarbonyl substituted n,n'-di(trimethoxybenzol) piperazines, process for preparing the same and therapeutical compounds compounds containing | |
| NO144072C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 5-endo-(3-indolkarbonyloksy)-n-(amino-lavere-alkyl)-bicyklo-(82,2,1)-heptan-2,3-diendo-karboksylsyreimider | |
| NO156410C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6aaa-methylprednisolonderivater. | |
| NO144569C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt bis-(2-methyl-3-hydroxy-5-vinyl-pyrid-4-ylmethyl)-disulfid og farmasoeytisk godtagbare salter derav | |
| NO138027C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1,4-disubstituerte piperazinderivater | |
| DK0490769T3 (da) | Nye derivater af aminoalkylketon, fremgangsmåde til fremstilling deraf og deres terapeutiske anvendelse |